Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000604417 | SCV000732084 | likely benign | not specified | 2017-01-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV001841782 | SCV001346451 | likely benign | Cardiac arrhythmia | 2019-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001427756 | SCV001630441 | likely benign | Long QT syndrome | 2023-07-08 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001427756 | SCV004836462 | likely benign | Long QT syndrome | 2023-04-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004629258 | SCV005126901 | uncertain significance | Cardiovascular phenotype | 2024-06-04 | criteria provided, single submitter | clinical testing | The c.1596G>T variant (also known as p.A532A), located in coding exon 13 of the KCNQ1 gene, results from a G to T substitution at nucleotide position 1596. This nucleotide substitution does not change the alanine at codon 532. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may result in the creation or strengthening of a novel splice acceptor site. Based on the available evidence, the clinical significance of this variant remains unclear. |